1. Home
  2. ACTU vs NXDT Comparison

ACTU vs NXDT Comparison

Compare ACTU & NXDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACTU
  • NXDT
  • Stock Information
  • Founded
  • ACTU 2015
  • NXDT 2012
  • Country
  • ACTU United States
  • NXDT United States
  • Employees
  • ACTU N/A
  • NXDT N/A
  • Industry
  • ACTU
  • NXDT Investment Managers
  • Sector
  • ACTU
  • NXDT Finance
  • Exchange
  • ACTU NYSE
  • NXDT Nasdaq
  • Market Cap
  • ACTU 135.0M
  • NXDT 156.8M
  • IPO Year
  • ACTU 2024
  • NXDT N/A
  • Fundamental
  • Price
  • ACTU $9.76
  • NXDT $3.99
  • Analyst Decision
  • ACTU Strong Buy
  • NXDT
  • Analyst Count
  • ACTU 1
  • NXDT 0
  • Target Price
  • ACTU $20.00
  • NXDT N/A
  • AVG Volume (30 Days)
  • ACTU 68.4K
  • NXDT 133.6K
  • Earning Date
  • ACTU 05-15-2025
  • NXDT 01-01-0001
  • Dividend Yield
  • ACTU N/A
  • NXDT 9.66%
  • EPS Growth
  • ACTU N/A
  • NXDT N/A
  • EPS
  • ACTU N/A
  • NXDT 0.99
  • Revenue
  • ACTU N/A
  • NXDT N/A
  • Revenue This Year
  • ACTU N/A
  • NXDT N/A
  • Revenue Next Year
  • ACTU N/A
  • NXDT N/A
  • P/E Ratio
  • ACTU N/A
  • NXDT $6.41
  • Revenue Growth
  • ACTU N/A
  • NXDT N/A
  • 52 Week Low
  • ACTU $5.51
  • NXDT $5.89
  • 52 Week High
  • ACTU $11.99
  • NXDT $13.07
  • Technical
  • Relative Strength Index (RSI)
  • ACTU N/A
  • NXDT 62.64
  • Support Level
  • ACTU N/A
  • NXDT $3.31
  • Resistance Level
  • ACTU N/A
  • NXDT $4.20
  • Average True Range (ATR)
  • ACTU 0.00
  • NXDT 0.23
  • MACD
  • ACTU 0.00
  • NXDT 0.09
  • Stochastic Oscillator
  • ACTU 0.00
  • NXDT 85.39

About ACTU ACTUATE THERAPEUTICS INC

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

About NXDT NexPoint Diversified Real Estate Trust

NexPoint Diversified Real Estate Trust is a publicly traded REIT focused on opportunistic real estate investments in the United States. Their portfolio includes diverse commercial properties and investments across various real estate sectors and capital structures. The revenue sources of the company include rental income from office and retail properties, interest income from debt investments, dividend income from equity investments, and other ancillary income from tenants. The company operates through its operating partnership and wholly owned subsidiaries.

Share on Social Networks: